Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00096083
Recruitment Status : Completed
First Posted : November 9, 2004
Last Update Posted : October 23, 2013
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Delcath Systems Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : August 2012
  Study Completion Date : August 2012